News | April 19, 2025
GSK’s blenrep combinations approved by UK MHRA in relapsed/refractory multiple myeloma
Blenrep combinations could redefine treatment as early as first relapse where more effective options are needed
Blenrep combinations could redefine treatment as early as first relapse where more effective options are needed
The EIR was issued following an inspection of the facility conducted from June 10 to June 13, 2024
Genomics is transforming the future of modern medicine and treatment modalities across specialties
This change is subject to the approval of the shareholders of the company, the Ministry of Corporate Affairs and other statutory and regulatory authorities,
The approval was granted more than two months ahead of the Prescription Drug User Fee Act goal date
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
Dr Reddy’s said scheme of amalgamation was carried with adherence to all the legal requirements including tax laws
Nadda noted that on the basis of economic caste census, 50 crore people were brought under this scheme
Findings likely to generate hypotheses about potential new uses of drugs
Subscribe To Our Newsletter & Stay Updated
